AstraZeneca’s Anselamimab Misses Primary Endpoint in Amyloidosis Trials, Shows Promise in Subgroup
Akero Therapeutics Inc. (NASDAQ:AKRO) is one of the best mid cap pharma stocks to buy.
Posts Tagged ‘NASDAQ:AKRO’
10 Best Mid Cap Pharma Stocks to Buy
On July 14, Emily Field, the head of European pharma research at Barclays, appeared on CNBC to discuss which drug makers would be most impacted by 30% US tariffs on EU imports...
Why Akero Therapeutics, Inc. (AKRO) Skyrocketed Today
We recently published a list of These 10 Firms Just Beat the Market Today. In this article, we are going to take a look at where Akero Therapeutics, Inc.
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
10 Best Performing Mid Cap Stocks to Buy According to Analysts
On February 7, Simeon Hyman, Global Investment Strategist at ProShares Advisors, appeared on CNBC to discuss the upcoming jobs report and its expected impact on the market.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
10 Best Performing Healthcare Stocks So Far in 2025
Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year.
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
5 Stocks That Started The Year On A High
Anyone who’s looked at the market in the last couple of weeks will know that there were some events that shook investors.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
10 Most Promising Small-Cap Stocks According to Hedge Funds
Small-cap stocks are offering a myriad of opportunities to investors and are expected to go higher.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we discuss the 5 stocks receiving price-target hike from Wall Street analysts.
Insider Buying Alert: These 10 Stocks are Seeing Significant Insider Activity
In this article, we will take a look at the 10 stocks that are seeing significant buy-side insider activity.
5 Best Small-Cap Growth Stocks to Buy Now
Stem, Inc. (NYSE:STEM) is another technology company headquartered in San Francisco, California.
5 Best Performing NASDAQ Stocks in 2022
CTI BioPharma Corp. (NASDAQ:CTIC) was incorporated in 1991 and is headquartered in Seattle, Washington.
5 Best Performing Biotech Stocks in 2022
Verona Pharma plc (NASDAQ:VRNA) is a London-based clinical stage biopharmaceutical company, focused on development and commercialization of therapies for the treatment of respiratory...
10 Best Small-Cap Stocks To Buy Now
Small-cap stocks are often considered riskier but also more profitable than large-cap stocks. Many small-caps are younger firms with meaningful growth potential.
Is AKRO A Good Stock To Buy Now?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money ...
Is Akero Therapeutics, Inc. (AKRO) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Dumping Akero Therapeutics, Inc. (AKRO)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Hedge Funds Have Never Been This Bullish On Akero Therapeutics, Inc. (AKRO)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Hedge Fund and Insider Trading News: Kyle Bass, Elliott Management, Arlington Capital, Akero Therapeutics Inc (AKRO), Lattice Semiconductor Corp (LSCC), and More
Elliott Management Corp. had built a position in Allergan Plc and was pushing to split the company before AbbVie Inc.
